Q: What's your view for the health-care sector?
A: Health care's a fairly broad sector. I'd say in the pharma arena, the large-cap companies are of limited appeal, except for J&J. The large biotech companies have appeal -- Amgen (AMGN ), Genentech (DNA ). A portfolio of small biotech companies makes sense as well.